featured
Risk of HBV Reactivation in Patients Treated With Immunotherapy for Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of Hepatitis B Virus Reactivation in Patients Treated With Immunotherapy for Anti-cancer Treatment
Clin. Gastroenterol. Hepatol. 2022 Apr 01;20(4)898-907, S Yoo, D Lee, JH Shim, KM Kim, YS Lim, HC Lee, C Yoo, BY Ryoo, J ChoiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.